Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
CALL
Accenture
ACN
$110B
| $139M | 0.04% |
533,600
-78,200
| -13% | -$18.7M |
|
377
PUT
Merck
MRK
$332B
| $139M | 0.04% |
1,780,342
+338,713
| +23% | +$25.9M |
|
|
SYNH
378
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $139M | 0.04% |
2,033,457
+823,393
| +68% | +$51.3M |
|
379
PUT
Amgen
AMGN
$226B
| $138M | 0.04% |
601,500
+66,000
| +12% | +$15.2M |
|
380
PUT
Paycom
PAYC
$10.1B
| $138M | 0.04% |
305,300
+101,600
| +50% | +$40.5M |
|
381
CALL
S&P Global
SPGI
$125B
| $138M | 0.04% |
419,700
+115,700
| +38% | +$39M |
|
382
Match Group
MTCH
$8.54B
| $138M | 0.04% |
912,176
-1,567,272
| -63% | -$207M |
|
383
iShares Expanded Tech-Software Sector ETF
IGV
$15.2B
| $138M | 0.04% |
1,945,890
+717,430
| +58% | +$47.5M |
|
384
CALL
RTX Corp
RTX
$297B
| $137M | 0.04% |
1,922,008
+685,708
| +55% | +$45.1M |
|
385
PUT
Coca-Cola
KO
$377B
| $137M | 0.04% |
2,497,900
-1,196,600
| -32% | -$61.9M |
|
386
Boeing
BA
$182B
| $137M | 0.04% |
639,372
-496,718
| -44% | -$95.5M |
|
387
Boston Beer
SAM
$1.9B
| $137M | 0.04% |
137,601
+74,812
| +119% | +$71.8M |
|
388
PUT
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $136M | 0.04% |
2,090,600
+9,800
| +0.5% | +$597K |
|
389
PUT
Simon Property Group
SPG
$71.9B
| $136M | 0.04% |
1,592,300
+195,500
| +14% | +$14.9M |
|
390
AbbVie
ABBV
$443B
| $136M | 0.04% |
1,265,937
+786,013
| +164% | +$75.5M |
|
391
PUT
Okta
OKTA
$27B
| $136M | 0.04% |
533,000
-38,500
| -7% | -$9.15M |
|
392
Advanced Micro Devices
AMD
$790B
| $135M | 0.04% |
1,473,668
+1,077,976
| +272% | +$93M |
|
393
Global Payments
GPN
$25.1B
| $134M | 0.03% |
623,903
-485,412
| -44% | -$90.5M |
|
394
CALL
Lockheed Martin
LMT
$138B
| $134M | 0.03% |
378,500
-166,000
| -30% | -$61M |
|
395
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$22.9B
| $134M | 0.03% |
4,280,400
-345,800
| -7% | -$10.9M |
|
|
SBNY
396
DELISTED
Signature Bank
SBNY
| $134M | 0.03% |
990,638
-286,452
| -22% | -$29.9M |
|
397
PUT
Sea Limited
SE
$75.7B
| $133M | 0.03% |
669,200
-4,400
| -0.7% | -$783K |
|
398
W.R. Berkley
WRB
$26.2B
| $133M | 0.03% |
4,502,894
+2,555,213
| +131% | +$73.7M |
|
399
Performance Food Group
PFGC
$16.4B
| $133M | 0.03% |
2,783,267
+666,916
| +32% | +$28.1M |
|
400
CALL
RH
RH
$3.4B
| $132M | 0.03% |
295,500
+43,700
| +17% | +$18M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.